Will a pill a day prevent HIV? Anticipating the results of the tenofovir “PrEP” trials

This 2005 report examines the issues surrounding the tenofovir trials and makes recommendations for ensuring that trials are carried out ethically and that provisions are made for dealing with the results of the trials when they are available. The report also calls for more concerted coordination and advance planning to accelerate evaluation, licensing, and access to PrEP.

Gay and Bisexual Men Who Have Sex with Men
Accelerating Product Innovation
Tracking and Translating the Field